Pfizer, Tris Pharma Settle For $41.5 Mn In Texas ADHD Drug Case [Barron's]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Barrons
The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), according to a statement from Ken Paxton, the southern US state's Republican attorney general. Advertisement - Scroll to Continue Under the settlement, Pfizer expressly denies "any and all liability and wrongdoing," the New York City-based company said in a statement Wednesday. Between 2012 and 2018, tests showed the liquid drug Quillivant XR frequently did not dissolve in the body as it was meant to do -- and therefore did not work, Paxton said. "Pfizer and Tris Pharma provided adulterated drugs to children for years and changed test results in order to obtain the benefit of taxpayer-funded Medicaid reimbursement," Paxton said in a statement. "Under my watch, Big Pharma will not escape justice for lying about the effectiveness of its drugs." Advertisement - Scroll to Continue
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer: The Market Is Still Wrong About It [Seeking Alpha]Seeking Alpha
- FDA chief claims Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- FDA chief says Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Jim Cramer on Pfizer: “I Would Hold on to It” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website